Trading Review on Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Investors following the charts for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) may be taking note that the current ATR level is 2.08. The ATR or average true range was developed by J. Welles Wilder. The ATR tracks the distance that the stock price is moving each period. The ATR may be used by investors and traders to gauge when markets are likely to range, when extreme stock price levels are being approached, or if there is significant interest in a trend. ATR may be used as an indicator, but it may not predict anything by itself. Higher ATR’s may indicate that the stock is trending, and smaller ATR’s may be indicitive of stock price consolidation. The ATR range will be positive whether or not shares are trending up or down. ATR may allow traders to more accurately buy or sell into certain trends.

When setting up a personal stock investment strategy, individual investors often set short-term and long-term goals. These goals may address the questions of specific objectives, how to start achieving these objectives, and the amount of risk that the individual is comfortable taking on. Once goals are in place, the investor can start to think about the overall strategy, and how they are going to start building the portfolio. A large number of investors will not reach their goals that they created at the outset. There may be many different reasons for this, but getting caught up in the excitement and chasing performance may be near the top of the list. Investors who figure out how to focus on the right information are typically more prepared for the numerous challenges that arise when dealing with the equity market.

Tracking some historical performance information for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), we have noted that performance for the previous week is -1.20%. YTD, the stock has performed 31.50%. Over the last full-year, shares have performed 27.13%. For the previous month, company shares are -4.53%. For the last quarter, the stock has performed -7.41%. Tracking some recent volatility numbers, shares are 4.08% for the week, and 3.53% for the past month.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has a current consensus broker rating of 1.80. This rating follows a scale where a 1 or a 2 would represent a consensus Buy recommendation. A rating of 4 or 5 would indicate a consensus Sell recommendation. A rating of 3 would represent a Hold recommendation. Checking in on the RSI or relative strength index, we see that the 14-day level is 40.35. The RSI operates in a range-bound area with values between 0 and 100. When the RSI line heads higher, the stock may be showing strength. The opposite is the case when the RSI line is moving down. RSI may be used to spot overbought or oversold conditions. An RSI reading over 70 would be considered overbought, and a value under 30 would indicate oversold conditions. A level of 50 would represent neutral market momentum.

At current stock price levels, we have noted that Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares are separated -20.56% from the 52 week high and 60.21% off of the 52 week low. From the open, the stock has seen a change of -2.59%. Looking at some other high/low data, the stock has been seen trading -20.56% away from the 50 day high and 4.15% off of the 50 day low. In terms of volume, the current value is near 323444. Investors may be keeping a close eye on unusual trading volume on company shares. A large increase or decrease in trading volume may suggest that other factors are present.

Stock market triumph can be just as much about learning how to minimize losses as it is about picking winning stocks. Not even the most seasoned professional investors are right all the time. Successful investors know how to act quickly and protect themselves from big losses. Sometimes those sure-fire stock picks don’t perform as planned. Being able to detach from any emotion that one might have to a certain stock can help with being able to cut and run when the time is right. Investors will often try to convince themselves that the research was correct and the stock will bounce back, but this can lead to extended losses and future portfolio disaster. Sometimes markets or individual stocks will move in a direction that nobody expected. Being able to take a punch and move on is what may keep investors from experiencing quick defeat in the stock market.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Comment

Your email address will not be published. Required fields are marked *